Finance

Lists
524731:BOM
Jenburkt Pharmaceuticals Ltd
916,05 ₹
+0,01%
(+0,050) 1D
16 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524731...
Open
942,00 ₹
High
952,45 ₹
Low
916,05 ₹
Mkt. cap
4,69 մլրդ
Avg. vol.
463,00
Volume
243,00
P/E ratio
12,31
52-wk high
1 321,00 ₹
52-wk low
880,10 ₹
EPS
74,40 ₹
Shares outstanding
4,59 մլն
No. of employees
801
Open
942,00 ₹
High
952,45 ₹
Low
916,05 ₹
Mkt. cap
4,69 մլրդ
Avg. vol.
463,00
Volume
243,00
P/E ratio
12,31
52-wk high
1 321,00 ₹
52-wk low
880,10 ₹
EPS
74,40 ₹
Shares outstanding
4,59 մլն
No. of employees
801
News stories
From web sources and news partners
About Jenburkt Pharmaceuticals Ltd
CEO-
Employees801
Founded1985
Headquarters-
Sector-
Last report
06 օգս, 2026 թ.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
355,12 մլն / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
455,58 մլն
430,24 մլն
446,32 մլն
355,12 մլն
Cost of goods sold
83,56 մլն
87,89 մլն
101,21 մլն
63,22 մլն
Cost of revenue
83,56 մլն
87,89 մլն
101,21 մլն
63,22 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
139,32 մլն
147,14 մլն
95,15 մլն
130,25 մլն
Operating expense
248,41 մլն
276,38 մլն
191,98 մլն
238,04 մլն
Total operating expenses
331,97 մլն
364,27 մլն
293,19 մլն
301,26 մլն
Operating income
123,60 մլն
65,97 մլն
153,13 մլն
53,86 մլն
Other non operating income
20,79 մլն
18,15 մլն
-60,40 մլն
15,13 մլն
EBT including unusual items
143,32 մլն
82,97 մլն
137,08 մլն
67,69 մլն
EBT excluding unusual items
143,32 մլն
82,97 մլն
171,23 մլն
67,69 մլն
Income tax expense
41,69 մլն
23,65 մլն
28,59 մլն
8,84 մլն
Effective tax rate
29,09%
28,51%
20,85%
13,05%
Other operating expenses
101,64 մլն
120,92 մլն
88,74 մլն
101,38 մլն
Net income
101,63 մլն
59,31 մլն
108,49 մլն
58,86 մլն
Net profit margin
22,31%
13,79%
24,31%
16,57%
Earnings per share
-
-
-
-
Interest and investment income
-
-
57,47 մլն
-
Interest expense
-1,07 մլն
-1,16 մլն
-392,00 հզր
-1,30 մլն
Net interest expenses
-1,07 մլն
-1,16 մլն
57,07 մլն
-1,30 մլն
Depreciation and amortization charges
7,44 մլն
8,32 մլն
8,09 մլն
6,41 մլն
EBITDA
130,94 մլն
71,11 մլն
158,72 մլն
59,45 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps